Yzi Labs comments on CEA Industries’ implementation of poison pill strategy and charter changes

YZi Labs is assessing CEA Industries’ use of a poison pill strategy to hinder shareholder rights, with the latter postponing its annual meeting scheduled for December 17th, 2025.

YZi Labs denied CEA’s assertions about not exploring alternative token strategies, referencing CEO David Namdar’s comments in November 2025 about transitioning to assets like Solana.